asco guidelines: her2 testing and clinical decision making in gastroesophageal adenocarcinoma
Published 4 months ago • 4 plays • Length 5:26Download video MP4
Download video MP3
Similar videos
-
3:24
cap-ascp-asco her2 testing and clinical decision-making in gastroesophageal adenocarcinoma guideline
-
8:59
guidelines and approaches to her2 testing for breast cancer
-
1:23
pathologist dr. elizabeth hammond discusses the asco/cap her2 testing guideline revisions
-
46:51
her2 in breast cancer: testing guidelines and new treatment approaches
-
1:03:11
how to improve her2 testing accuracy: incorporating the 2018 asco/cap focused update
-
36:00
updates in her2 testing in breast cancer
-
5:33
case 1: guidelines for her2 testing in breast cancer
-
1:03:11
how to improve her2 testing accuracy: incorporating the 2018 asco/cap focused update
-
8:29
approaching her2 testing in breast cancer
-
4:19
recommendations for her2 testing in breast cancer
-
2:19
asco gi 2021: her2-positive gastric cancer, polo and key trials in progress
-
28:57
evolution of her2-targeted therapy in gastroesophageal adenocarcinoma
-
8:12
her2 testing in metastatic breast cancer
-
2:59
clinical implications of her2 in gi cancers
-
31:17
molecular testing and the role of her2 in managing advanced colorectal cancer
-
2:07
recommendations for her2 testing in metastatic breast cancer
-
12:23
management of locally advanced rectal cancer guideline